683 Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
1,150,000
+150,000
| +15% | +$1.37M | 0.69% | 29 |
|
|
2025
Q1 | $7.95M | Buy |
1,000,000
+370,000
| +59% | +$2.94M | 0.55% | 43 |
|
|
2024
Q4 | $3.42M | Buy |
630,000
+30,000
| +5% | +$163K | 0.21% | 66 |
|
|
2024
Q3 | $4.33M | Buy |
600,000
+100,000
| +20% | +$722K | 0.33% | 56 |
|
|
2024
Q2 | $5.43M | Buy |
500,000
+300,000
| +150% | +$3.26M | 0.41% | 48 |
|
|
2024
Q1 | $3.75M | Buy |
+200,000
| New | +$3.75M | 0.27% | 54 |
|